| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS42000975 | EBV | ENSG00000009724.18 | protein_coding | MASP2 | No | No | 10747 | O00187 |
| TVIS10015692 | HBV | ENSG00000009724.18 | protein_coding | MASP2 | No | No | 10747 | O00187 |
| TVIS10025754 | HBV | ENSG00000009724.18 | protein_coding | MASP2 | No | No | 10747 | O00187 |
| TVIS30011165 | HIV | ENSG00000009724.18 | protein_coding | MASP2 | No | No | 10747 | O00187 |
| TVIS30022197 | HIV | ENSG00000009724.18 | protein_coding | MASP2 | No | No | 10747 | O00187 |
| TVIS20003296 | HPV | ENSG00000009724.18 | protein_coding | MASP2 | No | No | 10747 | O00187 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | MASP2 |
|---|---|
| DrugBank ID | DB16418 |
| Drug Name | Narsoplimab |
| Target ID | BE0004630 |
| UniProt ID | O00187 |
| Regulation Type | antagonist |
| PubMed IDs | 32681658 |
| Citations | Elhadad S, Chapin J, Copertino D, Van Besien K, Ahamed J, Laurence J: MASP2 levels are elevated in thrombotic microangiopathies: association with microvascular endothelial cell injury and suppression by anti-MASP2 antibody narsoplimab. Clin Exp Immunol. 2021 Jan;203(1):96-104. doi: 10.1111/cei.13497. Epub 2020 Aug 5. |
| Groups | Investigational |
| Direct Classification | Peptides |
| SMILES | |
| Pathways | |
| PharmGKB | |
| ChEMBL |
